BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Art Pappas will participate on a panel at the C21 BioVentures Conference in Napa, Ca titled "Structured Acquisitions: Win-Win or Lose-Lose?"
News | 04. 08. 2009
